Merck & Co Inc - Company Profile
Powered by 
All the data and insights you need on Merck & Co Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Merck & Co Inc Strategy Report
- Understand Merck & Co Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
View moreMerck & Clinical Trials
Determine Merck & Co Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.
A sample of Merck & Clinical Trials data
| Trial Title | Trial Identifier | Drug Name | Therapy Area | Indication | Trial Phase | Trial Status | Sponsor |
|---|---|---|---|---|---|---|---|
| Deserunt mollit sunt Lorem | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Pfizer Inc |
| A phase Ib/II Clinical Study of GFH925 with ERBITUX (cetuximab) in Non-Small Cell Lung Cancer | GDCT0474912 | cetuximab; GF-105 | Oncology | Non-Small Cell Lung Cancer | Phase I/II | Planned | GenFleet Therapeutics (Shanghai) Inc |
| A Study of Adjuvant Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab for Resected High-Risk Melanoma in Participants with High-Risk Stage II-IV Melanoma (MK-7684A-010/KEYVIBE-010) | GDCT0474874 | (pembrolizumab+vibostolimab); pembrolizumab | Oncology | Melanoma | Phase III | Planned | Merck & Co Inc |
| A Clinical Study of DR30303 in Combination with KEYTRUDA (pembrolizumab) in Subjects with Gastric or Gastroesophageal Junction Cancer | GDCT0474816 | DR-30303; pembrolizumab | Oncology | Gastric Cancer; Gastroesophageal (GE) Junction Carcinomas | Phase I | Planned | Zhejiang Doer Biologics Corp |
Feature
GlobalData’s Clinical Trials database (CTDB) is a highly comprehensive source of Clinical Trials.
The database covers planned, ongoing, completed and terminated/suspended/withdrawn clinical trials.
Clinical Trials database provides intelligence on global clinical trials for all indications. The data is sourced from:
- 250+ clinical trial registries
- 200+ scientific and investor conferences, company pipelines, press releases, and SEC filings.
Benefit
The Clinical Trials database collects information on various parameters to provide a Clinical Trial overview as well as Clinical Trial details, Drug details, Patient details, Trial Results, Location(s)/Sponsor(s) and Contact Detail(s).
Access:
- Detailed trial information.
- Drug information.
- Patient information, including inclusion and exclusion criteria.
- Trial results, as reported in the public domain.
- Biomarkers used for patient stratification/selection & outcome measures.
- Enrolment parameters.
- Investigators involved in clinical trials.
- Trials sites and locations.
- Contact information.
Value
Competitive Activity – keep an eye on planned or ongoing trials, as well as the trials currently recruiting and who is sponsoring them.
Geographic Analysis - see where trials are being run.
Trend Analysis - view top sponsors, indications, phase, status and more with Trial Analytics.
Find information on trials contacts, as well as Site and Investigator information.
Get information on trial successes and failures.
Get intelligence on CROs engaged in clinical trials.
Use as a business development tool for CROs.
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer